ArticleJournal of clinical biochemistry and nutrition2022

Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study.

Masahide Hamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.